BioLineRx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioLineRx and other ETFs, options, and stocks.About BLRX
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors.
CEOPhilip Adam Serlin
CEOPhilip Adam Serlin
Employees28
Employees28
HeadquartersModi'in, HaMerkaz
HeadquartersModi'in, HaMerkaz
Founded2003
Founded2003
Employees28
Employees28
BLRX Key Statistics
Market cap14.71M
Market cap14.71M
Price-Earnings ratio-2.47
Price-Earnings ratio-2.47
Dividend yield—
Dividend yield—
Average volume27.95K
Average volume27.95K
High today$3.38
High today$3.38
Low today$3.25
Low today$3.25
Open price$3.37
Open price$3.37
Volume6.39K
Volume6.39K
52 Week high$14.70
52 Week high$14.70
52 Week low$2.30
52 Week low$2.30
Stock Snapshot
The current BioLineRx(BLRX) stock price is $3.36, with a market capitalization of 14.71M. The stock trades at a price-to-earnings (P/E) ratio of -2.47.
During the trading session on 2025-12-06, BioLineRx(BLRX) shares reached a daily high of $3.38 and a low of $3.25. At a current price of $3.36, the stock is +3.4% higher than the low and still -0.6% under the high.
Trading activity shows a volume of 6.39K, compared to an average daily volume of 27.95K.
The stock's 52-week range extends from a low of $2.30 to a high of $14.70.
The stock's 52-week range extends from a low of $2.30 to a high of $14.70.